ARGYLE MEDICAL LIMITED
No material changes in the last 30 days.
No snapshot from 90 days ago — start tracking from today.
No snapshot from 180 days ago — start tracking from today.
Opportunity 71/100 (strong), bankability 70/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (76/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Signals from accounts
Derived from iXBRL accounts · accounting standard not declaredKey financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2025-03-31 | 2024-03-31 |
|---|---|---|
| Total assets | £37.7k | £8.3k |
| Current assets | £36.7k | £8.3k |
| Net assets | £10.7k | £8.3k |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
Recent activity
- • 1 confirmation-statement
- • 1 confirmation-statement
- • 1 accounts
Corporate timeline (6 events)Click to expand
- 2025-12-23📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-12-26📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2023-09-04📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2022-03-15🏢Company incorporatedAs ARGYLE MEDICAL LIMITED
- 2022-03-15➕OKUDO, Unoma Chidinma, Dr appointeddirector
- 2022-03-15📄incorporation-companyincorporation · NEWINC
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- +Sole director: Only one active director — all governance concentrated on one person.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Dr Unoma Chidinma Okudo Individual · British · DOB 10/1986 · age 40 | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 15/03/2022 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · G postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| OPTICAL EXPRESS LIMITED→ SC161469 · est 1995 | £80.82M £58.19M–£103.45M | — | — | 54900 | 30y | 85 | 58y |
| GP MATTERS LIMITED→ SC424457 · est 2012 | £3.46M £2.49M–£4.43M | — | — | 500 | 14y | 85 | 61y |
| GATE HEALTHCARE LIMITED→ SC106549 · est 1987 | £2.91M £2.09M–£3.72M | — | — | 178 | 38y | 82 | 60y |
| LORIMER CARE HOMES LIMITED→ SC412450 · est 2011 | £2.26M £1.63M–£2.89M | — | — | 0 | 14y | 82 | 60y |
| GLENFAIRN LIMITED→ SC087540 · est 1984 | £1.83M £1.32M–£2.34M | — | — | 84 | 42y | 82 | 60y |
| ASPIRE HOUSING & PERSONAL DEVELOPMENT SERVICES LIMITED→ SC231773 · est 2002 | — | — | £354.7k | — | 24y | 83 | 77y |
| BCERTA LTD.→ SC355831 · est 2009 | — | — | — | — | 17y | 83 | 67y |
| COMMONWEALTH DENTAL PRACTICE LTD.→ SC381148 · est 2010 · no financials extracted | — | — | — | — | 15y | 83 | 58y |
| DAVID LIVINGSTONE INTERNATIONAL LIMITED→ SC118899 · est 1989 | — | — | £150.4k | — | 36y | 83 | 90y |
| DOON CARE LTD.→ SC262088 · est 2004 | — | — | £1.46M | — | 22y | 83 | 87y |
| DUNDONALD HOUSE NURSING HOME LIMITED→ SC296431 · est 2006 | — | — | — | — | 20y | 83 | 64y |
| FORWARD STEPS NURSERY LTD.→ SC235287 · est 2002 | — | — | £107.9k | — | 23y | 83 | 59y |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.